Several market trends are influencing competition in the cancer treatment landscape. The growing focus on precision medicine, which tailors treatments to individual genetic profiles, is driving the development of highly specialized therapies. Additionally, the rise of biosimilars is increasing competition and reducing costs for biologic drugs. Technological advancements, such as artificial intelligence and machine learning, are also accelerating drug discovery and development processes.
